Volume 31, Issue 4 pp. 448-451

Urological Note

Percutaneous cryoablation of renal cell carcinomas in patients with Von Hippel-Lindau disease: Functional and oncological outcomes

Akihiro Matsukawa MD,

Akihiro Matsukawa MD

orcid.org/0000-0002-3324-762X

Department of Urology, The Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Search for more papers by this author

Takafumi Yanagisawa MD, PhD,

Takafumi Yanagisawa MD, PhD

orcid.org/0000-0002-7410-0712

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Search for more papers by this author

Kanichiro Shimizu MD, PhD,

Kanichiro Shimizu MD, PhD

Department of General Medicine, The Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan

Search for more papers by this author

Shahrokh F. Shariat MD, PhD,

Shahrokh F. Shariat MD, PhD

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia

Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan

Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

Department of Urology, Weill Cornell Medical College, New York, New York, USA

Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria

Search for more papers by this author

Takahiro Kimura MD, PhD,

Takahiro Kimura MD, PhD

orcid.org/0000-0002-5673-1553

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author

Jun Miki MD, PhD,

Corresponding Author

Jun Miki MD, PhD

[email protected]

orcid.org/0000-0002-4638-8640

Department of Urology, The Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan

Search for more papers by this author

Akihiro Matsukawa MD,

Akihiro Matsukawa MD

orcid.org/0000-0002-3324-762X

Department of Urology, The Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Search for more papers by this author

Takafumi Yanagisawa MD, PhD,

Takafumi Yanagisawa MD, PhD

orcid.org/0000-0002-7410-0712

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Search for more papers by this author

Kanichiro Shimizu MD, PhD,

Kanichiro Shimizu MD, PhD

Department of General Medicine, The Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan

Search for more papers by this author

Shahrokh F. Shariat MD, PhD,

Shahrokh F. Shariat MD, PhD

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia

Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan

Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

Department of Urology, Weill Cornell Medical College, New York, New York, USA

Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria

Search for more papers by this author

Takahiro Kimura MD, PhD,

Takahiro Kimura MD, PhD

orcid.org/0000-0002-5673-1553

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author

Jun Miki MD, PhD,

Corresponding Author

Jun Miki MD, PhD

[email protected]

orcid.org/0000-0002-4638-8640

Department of Urology, The Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan

Search for more papers by this author

First published: 02 January 2024

https://doi.org/10.1111/iju.15381

Share a link

Email
Wechat
Bluesky

CONFLICT OF INTEREST STATEMENT

Shahrokh F. Shariat received follows: Honoraria: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, Takeda. Consulting or Advisory Role: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, Takeda. Speakers Bureau: Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, Takeda. Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen and Sanofi. The other authors declare no conflicts of interest associated with this manuscript.

References

1Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. von Hippel-Lindau disease. Lancet. 2003; 361: 2059–2067.
10.1016/S0140-6736(03)13643-4
CAS PubMed Web of Science® Google Scholar
2Johnson A, Sudarshan S, Liu J, Linehan WM, Pinto PA, Bratslavsky G. Feasibility and outcomes of repeat partial nephrectomy. J Urol. 2008; 180: 89–93. discussion 93.
10.1016/j.juro.2008.03.030
PubMed Web of Science® Google Scholar
3Yanagisawa T, Mori K, Kawada T, Motlagh RS, Mostafaei H, Quhal F, et al. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: a systematic review and meta-analysis. Urol Oncol. 2022; 40: 315–330.
10.1016/j.urolonc.2022.04.002
PubMed Web of Science® Google Scholar
4Yanagisawa T, Miki J, Shimizu K, Motohashi K, Enoki K, Egawa S. Residue and recurrence in percutaneous cryoablation for cT1 renal tumor: clinical utility and feasibility of salvage cryoablation with iodized oil marking. Int J Urol. 2022; 29: 472–474.
10.1111/iju.14809
PubMed Web of Science® Google Scholar
5Yanagisawa T, Miki J, Shimizu K, Fukuokaya W, Urabe F, Mori K, et al. Functional and oncological outcome of percutaneous cryoablation versus laparoscopic partial nephrectomy for clinical T1 renal tumors: a propensity score-matched analysis. Urol Oncol. 2020; 38: 938.e1–938.e7.
10.1016/j.urolonc.2020.09.024
PubMed Web of Science® Google Scholar
6Bratslavsky G, Liu JJ, Johnson AD, Sudarshan S, Choyke PL, Linehan WM, et al. Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol. 2008; 179: 67–70.
10.1016/j.juro.2007.08.150
PubMed Web of Science® Google Scholar

Volume31, Issue4

April 2024

Pages 448-451

Percutaneous cryoablation of renal cell carcinomas in patients with Von Hippel-Lindau disease: Functional and oncological outcomes

CONFLICT OF INTEREST STATEMENT

References

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Percutaneous cryoablation of renal cell carcinomas in patients with Von Hippel-Lindau disease: Functional and oncological outcomes

CONFLICT OF INTEREST STATEMENT

References

References

Related

Information